It's no secret that GLP-1 medications like Ozempic, Zepbound and Wegovy are helping people achieve amazing health and weight ...

When an FDA-approved drug is in shortage, compounding pharmacies may legally dispense generic versions for patients who can’t ...

In fact, one clinical trial indicated that only about 86% of the more than 800 participants achieved “clinically significant” weight loss after taking semaglutide, sold under the brands Ozempic and ...

Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...

The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy ...

Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...

Two of Australia's biggest pharmacy brands are joining forces to become a multi-billion-dollar  pharmaceutical juggernaut. Here's why the competition watchdog gave the deal the all-clear.

The latest buzz around the popular weight loss drugs Ozempic, Mounjaro and Wegovy is to reduce the doseage and therefore avoid the vomiting and headaches that can happen on normal doses. But it’s not ...

Is India’s booming healthcare market part of your strategy, or are you overlooking a crucial opportunity? This is a question that U.S. healthcare companies should be pondering as India’s health and ...

Only 13 states currently offer Medicaid coverage for GLP-1 drugs, but the number of prescriptions and overall spending has ...

Compounded GLP-1s are essentially copies of popular weight loss medications made by manufacturers such as Novo Nordisk and Eli Lilly. Hims & Hers CEO Andrew Dudum said during the company's third ...

The results come as those drugs, like Wegovy and Ozempic, explode in popularity, leading to shortages as well as greater competition. Executives on Monday said those supply constraints were "not ...